If You'd Invested in FMC Stock 5 Years Ago, Here's How Much You'd Have Today (Spoiler: It's Not Pretty)
Key Points
The company's stock valuation looks attractive at recent levels.
But revenue has been falling and the company is exploring some extreme options.
Meet FMC Corp (NYSE: FMC) -- an agricultural sciences company that serves farmers by offering crop protection technologies to increase productivity. It's been around for more than 140 years, and has some strong core values, such as "We do things the right way. We are ethical, keep our commitments, and take responsibility for our actions." And "We create innovative solutions while preserving the environment for tomorrow."
How has the company's stock performed for investors? Well, not so terrifically. Those who invested, say, $10,000 five years ago would now be holding a stake worth around $2,000. Yikes!
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Image source: Getty Images.
That's an average annual loss of 27.6%, during a period when the S&P 500 averaged gains of 13.3%.
Looking forward
That's a terrible result, but a more important question for current shareholders and would-be shareholders alike is where the stock is likely to go from here. Arguably, those shares seem undervalued at recent levels, with a forward-looking price-to-earnings (P/E) ratio of 9.1, well below the five-year average of 12.4.
So what's the problem with FMC? Well, for one thing, it's carrying a lot of debt, in part due to acquisitions. It's also facing patent expirations for some key products. Worst of all, when the company reported its disappointing fourth-quarter results, management noted that it's exploring strategic options "including but not limited to the sale of the company."
Ugh, right? Well, on a more positive note, while revenue was down 12% year over year in the fourth quarter, the more recent first quarter of 2026 featured revenue down only 4%. The company is not necessarily doomed, though it has a lot of ground to regain. It's focusing on yield-boosting chemicals in a world where emerging markets will need to boost yields. It's selling its commercial India business to help pay down debt and is cutting costs.
It seems best to steer clear of FMC shares until its future is more clear and more rosy.
Selena Maranjian has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.